Anaerobic bacterial and protozoal cellular components (via free radical damage)

The entry "Anaerobic bacterial/protozoal cellular components via free radical damage" does **not** refer to a specific molecular target such as a receptor or enzyme. Instead, it describes the general mechanism by which certain antimicrobial agents—most notably nitroimidazoles like metronidazole—exert their effects on **anaerobic bacteria** and **protozoa**. These drugs are reduced inside susceptible microorganisms under low oxygen conditions; this reduction generates highly reactive **free radicals**, which then attack multiple essential cellular components including DNA, proteins (especially those with cysteine/methionine residues), lipid membranes, and other macromolecules[1][4][5]. The resulting oxidative stress leads to widespread molecular dysfunction and ultimately cell death.\n\nThis is not considered a canonical therapeutic target because it refers collectively to all vulnerable intracellular molecules rather than a defined protein or nucleic acid sequence. The term is therefore too broad for structured drug-target mapping; it encompasses any molecule within the pathogen susceptible to oxidation-induced injury rather than identifying one actionable entity.\n\nIn summary: this "target" represents an entire class of biomolecules damaged through non-specific chemical means rather than a discrete druggable target. It should be flagged as incorrect for use as a canonical therapeutic target name but can be useful when describing mechanisms of action for certain antimicrobials[1][4][5].

Other names

Cellular macromolecules targeted by free radicals in anaerobic bacteria and protozoaBacterial/protozoal cell structures affected by oxidative stress

Generation of cytotoxic free radicals that cause non-specific damage to DNA, proteins, and membranes within anaerobic bacteria and protozoa[1][4][5]